Treatment Regimens
Goals and Objectives of treatment
- To render the patient non-infectious, break the chain of transmission, and decrease the pool of infection.
- To decrease case fatality & morbidity by ensuring relapse-free cure.
- To minimise and prevent the development of drug resistance.
Directly Observed Treatment (DOT)
The National Tuberculosis Elimination Program envisages the provision of tuberculosis treatment under DOT. DOT is a supportive mechanism that ensures the best possible results in the treatment of TB. Here a treatment supporter helps the patient in taking the treatment and ensures treatment adherence. DOT ensures that patients receive the right drugs, in the right doses, at the right intervals, and for the right duration.
Treatment Regimen for Drug Susceptible Tuberculosis (DSTB)
For all TB patients whether being treated in the public or private sector, clinicians should follow Standards for TB care in India (STCI) guidelines. The Treatment for DSTB is given in two phases: the intensive phase and the continuation phase. Intensive Phase (IP): Consists of 8 weeks (56 doses) of isoniazid (H), rifampicin (R), pyrazinamide (Z), and ethambutol (E) given under direct observation in daily dosages. Continuation Phase (CP): Consists of 16 weeks (112 doses) of isoniazid, rifampicin, and ethambutol in daily dosages. The CP may be extended by 12-24 weeks in certain forms of TB like CNS TB, Skeletal TB, Disseminated TB, etc. based on the clinical decision of the treating physician on a case-to-case basis.
Treatment Regimen for Drug-Resistant Tuberculosis (DRTB)
The National Tuberculosis Elimination Program envisages the provision of tuberculosis treatment under DOT. DOT is a supportive mechanism that ensures the best possible results in the treatment of TB. Here a treatment supporter helps the patient in taking the treatment and ensures treatment adherence. DOT ensures that patients receive the right drugs, in the right doses, at the right intervals, and for the right duration.
- All oral High dose mono/poly Drug Resistant TB regimen: It is of 6 months with no separate Intensive Phase/Continuation Phase.
- Shorter Multi-Drug Resistant TB regimen: It is of 9-11 months with 4-6 months of Intensive Phase containing injectables and 5 months of the Continuation Phase.
- All oral longer Multi-Drug Resistant TB regimen: It is of 18-20 months with no separate Intensive Phase / Continuation Phase.
Long Term Follow-up
After completion of treatment, all patients, whether suffering from DSTB or DRTB, should be followed up clinically at the end of 6, 12, 18 & 24 months. In the presence of any clinical symptom (e.g., cough), sputum microscopy and/or culture of the biological specimen should be considered. This is important in detecting the recurrence of TB at the earliest.
Latest Updates
Tuberculosis and Travel: Navigating Risks and Precautions
According to the statistics by WHO, about 95% of the 9 million cases of TB worldwide have occurred in developing
A Chronicle of Tuberculosis: From Ancient Times to the Present
Tuberculosis, often referred to as TB, is an infectious airborne disease that has impacted millions of lives over the centuries.
The Global Impact of Tuberculosis on Dietary Trends
Since the beginning of the 21st century, governments worldwide have collaborated closely with healthcare professionals to forge a strategic path
Breakthrough Innovations by Indian Scientists Enhance TB Control Efforts
In the relentless battle against Tuberculosis (TB), Indian scientists have firmly established themselves at the forefront, spearheading innovative approaches poised
Strengthening the Battle Against Tuberculosis: The Vital Contribution of NGOs and Social Service Organizations
Tuberculosis (TB) continues to pose a significant global health challenge, impacting millions of individuals annually. In the midst of this
Harnessing Artificial Intelligence for Tuberculosis Diagnosis
Tuberculosis is the world’s leading killer in the case of infectious diseases, even when medical research offers testimony that it